Literature DB >> 15980361

3-Aminooxy-1-aminopropane and derivatives have an antiproliferative effect on cultured Plasmodium falciparum by decreasing intracellular polyamine concentrations.

Robin Das Gupta1, Tanja Krause-Ihle, Bärbel Bergmann, Ingrid B Müller, Alex R Khomutov, Sylke Müller, Rolf D Walter, Kai Lüersen.   

Abstract

The intraerythrocytic development of Plasmodium falciparum correlates with increasing levels of the polyamines putrescine, spermidine, and spermine in the infected red blood cells; and compartmental analyses revealed that the majority is associated with the parasite. Since depletion of cellular polyamines is a promising strategy for inhibition of parasite proliferation, new inhibitors of polyamine biosynthesis were tested for their antimalarial activities. The ornithine decarboxylase (ODC) inhibitor 3-aminooxy-1-aminopropane (APA) and its derivatives CGP 52622A and CGP 54169A as well as the S-adenosylmethionine decarboxlyase (AdoMetDC) inhibitors CGP 40215A and CGP 48664A potently affected the bifunctional P. falciparum ODC-AdoMetDC, with K(i) values in the low nanomolar and low micromolar ranges, respectively. Furthermore, the agents were examined for their in vitro plasmodicidal activities in 48-h incubation assays. APA, CGP 52622A, CGP 54169A, and CGP 40215A were the most effective, with 50% inhibitory concentrations below 3 microM. While the effects of the ODC inhibitors were completely abolished by the addition of putrescine, growth inhibition by the AdoMetDC inhibitor CGP 40215A could not be antagonized by putrescine or spermidine. Moreover, CGP 40215A did not affect the cellular polyamine levels, indicating a mechanism of action against P. falciparum independent of polyamine synthesis. In contrast, the ODC inhibitors led to decreased cellular putrescine and spermidine levels in P. falciparum, supporting the fact that they exert their antimalarial activities by inhibition of the bifunctional ODC-AdoMetDC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980361      PMCID: PMC1168667          DOI: 10.1128/AAC.49.7.2857-2864.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study.

Authors:  Miklos Pless; Karim Belhadj; Hans D Menssen; Wolfgang Kern; Bertrand Coiffier; Jürgen Wolf; Richard Herrmann; Eckhard Thiel; Doug Bootle; Ivo Sklenar; Christian Müller; Les Choi; Carl Porter; Renaud Capdeville
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

Review 2.  Targeting polyamines of parasitic protozoa in chemotherapy.

Authors:  S Müller; G H Coombs; R D Walter
Journal:  Trends Parasitol       Date:  2001-05

3.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

4.  The Plasmodium falciparum bifunctional ornithine decarboxylase, S-adenosyl-L-methionine decarboxylase, enables a well balanced polyamine synthesis without domain-domain interaction.

Authors:  C Wrenger; K Luersen; T Krause; S Muller; R D Walter
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

5.  In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase.

Authors:  S Müller; A Da'dara; K Lüersen; C Wrenger; R Das Gupta; R Madhubala; R D Walter
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

6.  Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo.

Authors:  S Singh; S K Puri; S K Singh; R Srivastava; R C Gupta; V C Pandey
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

7.  Determination of di-and polyamines by high-performance liquid chromatographic separation of their 5-dimethylaminonaphthalene-1-sulfonyl derivatives.

Authors:  N Seiler; B Knödgen
Journal:  J Chromatogr       Date:  1978-01-01

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

Review 10.  Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors.

Authors:  Nikolaus Seiler
Journal:  Curr Drug Targets       Date:  2003-10       Impact factor: 3.465

View more
  26 in total

1.  Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase of Plasmodium falciparum.

Authors:  Rishabh Jain; Rositsa Jordanova; Ingrid B Müller; Carsten Wrenger; Matthew R Groves
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-31

2.  A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.

Authors:  Veronica T Dufe; Daniel Ingner; Olle Heby; Alex R Khomutov; Lo Persson; Salam Al-Karadaghi
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

3.  Host pathogen protein interactions predicted by comparative modeling.

Authors:  Fred P Davis; David T Barkan; Narayanan Eswar; James H McKerrow; Andrej Sali
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

4.  Discovery of novel alkylated (bis)urea and (bis)thiourea polyamine analogues with potent antimalarial activities.

Authors:  Bianca K Verlinden; Jandeli Niemand; Janette Snyman; Shiv K Sharma; Ross J Beattie; Patrick M Woster; Lyn-Marie Birkholtz
Journal:  J Med Chem       Date:  2011-09-14       Impact factor: 7.446

5.  In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum.

Authors:  Dieudonné Ndjonka; Bärbel Bergmann; Christian Agyare; Flávia M Zimbres; Kai Lüersen; Andreas Hensel; Carsten Wrenger; Eva Liebau
Journal:  Parasitol Res       Date:  2012-04-05       Impact factor: 2.289

6.  Co-inhibition of Plasmodium falciparum S-adenosylmethionine decarboxylase/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses.

Authors:  Anna C van Brummelen; Kellen L Olszewski; Daniel Wilinski; Manuel Llinás; Abraham I Louw; Lyn-Marie Birkholtz
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

7.  Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.

Authors:  Nina Klee; Pui Ee Wong; Beatriz Baragaña; Farah El Mazouni; Margaret A Phillips; Michael P Barrett; Ian H Gilbert
Journal:  Bioorg Med Chem Lett       Date:  2010-06-17       Impact factor: 2.823

8.  Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

Authors:  Germán Plata; Tzu-Lin Hsiao; Kellen L Olszewski; Manuel Llinás; Dennis Vitkup
Journal:  Mol Syst Biol       Date:  2010-09-07       Impact factor: 11.429

Review 9.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Screening of potential targets in Plasmodium falciparum using stage-specific metabolic network analysis.

Authors:  Neel Dholakia; Pinakin Dhandhukia; Nilanjan Roy
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.